Guerin Mark Patrick 4
4 · Onconova Therapeutics, Inc. · Filed Jun 13, 2023
Insider Transaction Report
Form 4
Guerin Mark Patrick
Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2023-06-12$1.14/sh−1,575$1,791→ 22,116 total - Exercise/Conversion
Restricted Stock Units
2023-06-12−5,500→ 11,000 total→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2023-06-12+5,500→ 23,691 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.